Simplex Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,100
| Closed | -$1K | – | 10198 |
|
|
2023
Q4 | $1K | Sell |
2,100
-500
| -19% | -$301 | ﹤0.01% | 8633 |
|
|
2023
Q3 | $1K | Buy |
2,600
+500
| +24% | +$613 | ﹤0.01% | 8469 |
|
|
2023
Q2 | $6K | Buy |
+2,100
| New | +$6.35K | ﹤0.01% | 7863 |
|
|
2022
Q4 | – | Sell |
-780
| Closed | -$16K | – | 10744 |
|
|
2022
Q3 | $16K | Buy |
780
+560
| +255% | +$15.1K | ﹤0.01% | 7795 |
|
|
2022
Q2 | $5K | Sell |
220
-293
| -57% | -$9.97K | ﹤0.01% | 8888 |
|
|
2022
Q1 | $25K | Sell |
513
-577
| -53% | -$28.5K | ﹤0.01% | 8007 |
|
|
2021
Q4 | $76K | Sell |
1,090
-1,053
| -49% | -$88.7K | ﹤0.01% | 6668 |
|
|
2021
Q3 | $220K | Buy |
2,143
+23
| +1% | +$2.19K | ﹤0.01% | 5447 |
|
|
2021
Q2 | $213K | Buy |
2,120
+2,098
| +9,536% | +$204K | ﹤0.01% | 5580 |
|
|
2021
Q1 | $206K | Sell |
22
-20
| -48% | -$2.03K | ﹤0.01% | 4699 |
|
|
2020
Q4 | $348K | Sell |
42
-7
| -14% | -$597 | ﹤0.01% | 3895 |
|
|
2020
Q3 | $420K | Buy |
49
+25
| +104% | +$2.91K | ﹤0.01% | 3208 |
|
|
2020
Q2 | $226K | Buy |
+24
| New | +$1.32K | ﹤0.01% | 3860 |
|
|
2018
Q4 | – | Hold |
0
| – | -$2K | – | 7991 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7114 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7067 |
|
Simplex Trading's VBIV Position: Q3 2024 in Review
Simplex Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 19,351 shares — an estimated $12K sold.
Simplex Trading first reported a position in VBIV in Q2 2018 and held it in 18 quarters. The position peaked at $212K in Q3 2020. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Simplex Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 19,351 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $12K.
- Simplex Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 18 quarters.
- Simplex Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $212K in Q3 2020.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.